Peregrine Pharmaceuticals shares owned by Jennison Associates
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Jennison Associates
from 13F filings
Historical chart of Jennison Associates investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Jennison Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Peregrine Pharmaceuticals by Jennison Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $658k | 101k | 6.50 |
2023-09-30 | $21M | 2.3M | 9.44 |
2023-06-30 | $43M | 3.1M | 13.97 |
2023-03-31 | $55M | 2.9M | 18.76 |
2022-12-31 | $40M | 2.9M | 13.77 |
2022-09-30 | $55M | 2.9M | 19.12 |
2022-06-30 | $29M | 1.9M | 15.26 |
2022-03-31 | $26M | 1.3M | 20.37 |
2021-12-31 | $28M | 969k | 29.18 |
2021-09-30 | $23M | 1.1M | 21.57 |
2021-06-30 | $21M | 811k | 25.65 |
2021-03-31 | $4.1M | 223k | 18.23 |